search icon
nrxs-img

Neuraxis, Inc., Common Stock

NRXS

ASQ

$2.52

-$0.02

(-0.79%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$17.59M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
54.13K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2 L
$3.89 H
$2.52

About Neuraxis, Inc., Common Stock

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameNRXSSectorS&P500
1-Week Return-2.7%0.31%-1.26%
1-Month Return0.4%0.6%-4.16%
3-Month Return-10.64%-9.44%-0.46%
6-Month Return-16.28%-5.15%3.58%
1-Year Return5.44%0.33%22.47%
3-Year Return-58%4.53%25.13%

Financials

Dec '20Dec '21Dec '22Dec '23
Total Revenue1.93M2.72M2.68M2.46M[{"date":"2020-12-31","value":70.93,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.66,"profit":true},{"date":"2023-12-31","value":90.4,"profit":true}]
Cost of Revenue481.09K467.66K297.06K303.35K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":97.21,"profit":true},{"date":"2022-12-31","value":61.75,"profit":true},{"date":"2023-12-31","value":63.05,"profit":true}]
Gross Profit1.45M2.25M2.39M2.16M[{"date":"2020-12-31","value":60.69,"profit":true},{"date":"2021-12-31","value":94.39,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":90.33,"profit":true}]
Gross Margin75.08%82.81%88.94%87.67%[{"date":"2020-12-31","value":84.42,"profit":true},{"date":"2021-12-31","value":93.12,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.58,"profit":true}]
Operating Expenses5.57M5.22M5.76M8.82M[{"date":"2020-12-31","value":63.14,"profit":true},{"date":"2021-12-31","value":59.22,"profit":true},{"date":"2022-12-31","value":65.3,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(4.12M)(2.97M)(3.37M)(6.66M)[{"date":"2020-12-31","value":-412073800,"profit":false},{"date":"2021-12-31","value":-297003400,"profit":false},{"date":"2022-12-31","value":-337223800,"profit":false},{"date":"2023-12-31","value":-666449500,"profit":false}]
Total Non-Operating Income/Expense318.92K(94.93K)(4.15M)(13.32M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-29.77,"profit":false},{"date":"2022-12-31","value":-1300.55,"profit":false},{"date":"2023-12-31","value":-4177.6,"profit":false}]
Pre-Tax Income(3.73M)(3.03M)(4.78M)(14.63M)[{"date":"2020-12-31","value":-372614900,"profit":false},{"date":"2021-12-31","value":-302803200,"profit":false},{"date":"2022-12-31","value":-478006100,"profit":false},{"date":"2023-12-31","value":-1462668300,"profit":false}]
Income Taxes324.06K45.20K429.56K5.36M[{"date":"2020-12-31","value":6.04,"profit":true},{"date":"2021-12-31","value":0.84,"profit":true},{"date":"2022-12-31","value":8.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(4.05M)(3.07M)(5.21M)(19.99M)[{"date":"2020-12-31","value":-405021200,"profit":false},{"date":"2021-12-31","value":-307323200,"profit":false},{"date":"2022-12-31","value":-520961800,"profit":false},{"date":"2023-12-31","value":-1998949900,"profit":false}]
Income From Continuous Operations(3.73M)(3.03M)(4.78M)(14.63M)[{"date":"2020-12-31","value":-372614900,"profit":false},{"date":"2021-12-31","value":-302803200,"profit":false},{"date":"2022-12-31","value":-478006100,"profit":false},{"date":"2023-12-31","value":-1462668300,"profit":false}]
Income From Discontinued Operations----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(4.05M)(3.07M)(4.78M)(14.63M)[{"date":"2020-12-31","value":-405021200,"profit":false},{"date":"2021-12-31","value":-307323200,"profit":false},{"date":"2022-12-31","value":-478006100,"profit":false},{"date":"2023-12-31","value":-1462668300,"profit":false}]
EPS (Diluted)---(3.19)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-319.47,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NRXS
Cash Ratio 0.10
Current Ratio 0.24
Quick Ratio 0.23

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NRXS
ROA (LTM) -260.29%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NRXS
Debt Ratio Lower is generally better. Negative is bad. 2.57
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.57

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NRXS
Trailing PE NM
Forward PE NM
P/S (TTM) 7.76
P/B 0.00
Price/FCF NM
EV/R 7.25
EV/Ebitda NM

FAQs

What is Neuraxis, Inc. share price today?

Neuraxis, Inc. (NRXS) share price today is $2.52

Can Indians buy Neuraxis, Inc. shares?

Yes, Indians can buy shares of Neuraxis, Inc. (NRXS) on Vested. To buy Neuraxis, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NRXS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Neuraxis, Inc. be purchased?

Yes, you can purchase fractional shares of Neuraxis, Inc. (NRXS) via the Vested app. You can start investing in Neuraxis, Inc. (NRXS) with a minimum investment of $1.

How to invest in Neuraxis, Inc. shares from India?

You can invest in shares of Neuraxis, Inc. (NRXS) via Vested in three simple steps:

  • Click on Sign Up or Invest in NRXS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Neuraxis, Inc. shares
What is Neuraxis, Inc. 52-week high and low stock price?

The 52-week high price of Neuraxis, Inc. (NRXS) is $3.89. The 52-week low price of Neuraxis, Inc. (NRXS) is $2.

What is Neuraxis, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Neuraxis, Inc. (NRXS) is

What is Neuraxis, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Neuraxis, Inc. (NRXS) is 0.00

What is Neuraxis, Inc. dividend yield?

The dividend yield of Neuraxis, Inc. (NRXS) is 0.00%

What is the Market Cap of Neuraxis, Inc.?

The market capitalization of Neuraxis, Inc. (NRXS) is $17.59M

What is Neuraxis, Inc.’s stock symbol?

The stock symbol (or ticker) of Neuraxis, Inc. is NRXS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top